Systems and methods for assessing and treating medical conditions related to the central nervous system and for enhancing cognitive functions

• US 20090105521A1
• Filed: 10/03/2008
• Published: 04/23/2009
• Est. Priority Date: 09/13/2004
• Status: Abandoned Application

• Current Assignee: Neuronix Ltd.
• Original Assignee: Neuronix Ltd.
• Inventors: Bentwich, Jonathan
• Application Number:
  US12/285,417
• Publication Number:
  US 20090105521A1
• Time in Patent Office: Days
• US Class Current: 600/9
• CPC Class Codes: A61N 1/36025 for treating a mental or cerebral condition
• CPC Class Codes: A61N 1/36082 Cognitive or psychiatric applications, e.g. dementia or Alzheimer's disease
• CPC Class Codes: A61N 1/40 Applying electric fields by inductive or capacitive coupling microwave apparatus A61N5/00; Applying radio-frequency signals
• CPC Class Codes: A61N 2/006 for magnetic stimulation of nerve tissue
• CPC Class Codes: A61N 2/02 using magnetic fields produced by coils, including single turn loops or electromagnets A61N2/12 takes precedence
• CPC Class Codes: A61N 5/0613 Apparatus adapted for a specific treatment
• CPC Class Codes: G16H 20/30 relating to physical therapies or activities, e.g. physiotherapy, acupressure or exercising
• CPC Class Codes: G16H 20/40 relating to mechanical, radiation or invasive therapies, e.g. surgery, laser therapy, dialysis or acupuncture

Abstract

Systems and methods for diagnosing and treating various brain-related conditions, and/or for modifying at least one of cognitive, behavioral, or affective functions or skills in individuals. The method of diagnosing and treating a brain-related condition includes the steps of: (i) identifying at least a brain region associated with the brain-related condition; (ii) stimulating the brain region by employing at least one electrical, magnetic, electromagnetic, and photoelectric stimulus; (iii) optionally, stimulating at least one cognitive feature associated with the brain region; and (iv) optionally, subjecting the brain region to a treatment including at least one of cell replacement therapy, cell regenerative therapy and cell growth.

Claims

1. A device for assessing and enhancing particular cognitive, behavioral, or affective functions in a patient comprising:

a neurodiagnostic module for identifying an individual'"'"'s brain regions of interest and associated with particular functional, structural, or cognitive abnormalities and measuring the functional activation or structural maps, or corresponding cognitive performance for a particular task (or tasks) or during a resting period;

a computational module identifying the particular brain regions in an individual whose structure, function, or cognitive functions are deviant from their corresponding statistically-established health norms, or from their corresponding statistical norms for cognitively enhanced performance in a particular task;

a brain trait module for determining whether the identified brain regions from said computational module statistically fits within known structural, functional, or cognitive pathophysiology of a particular brain-related disease, or within established norms for enhanced or excellent cognitive or behavioral performance for a particular task;

a treatment module for computing precise individual-based brain and cognitive stimulation parameters needed to stimulate the particular identified brain regions; and

a stimulator module system for distributing, at least non-invasively, energy to stimulate the identified brain regions associated with the particular functional, structural, or cognitive abnormalities.

2. The device of claim 1, wherein the stimulator module system comprises:

at least one of a brain stimulator and a cognitive stimulator, the brain stimulator being configured to selectively stimulate brain regions deviant from their corresponding statistically-established health norms, or from their corresponding statistical norms for cognitively enhanced performance in a particular task.

3. The device of claim 2, further including at least one electrode in communication with at least one of ear, nose, scalp and mouth of an individual.

4. The device of claim 2, wherein the brain stimulator comprises at least one invasive stimulator operative to selectively provide singular or multiple site stimuli to one or more identified brain regions.

5. The device of claim 1, wherein the brain stimulator generates an excitatory or inhibitory stimulus energy.

6. The device of claim 1, wherein the brain stimulator module is configured to provide at least one of electrical, magnetic, electromagnetic and photoelectric stimulus.

7. The device of claim 1, wherein the treatment module further includes ROI threshold data and brain condition data that inputs the data into a trait-threshold inverse stimulation computation.

10. The device of claim 1, wherein the stimulation module system includes brain stimulation data, cognitive stimulation data, neuro-cognitive stimulation data, and a correspondingly interfaced brain stimulator, cognitive stimulator and neuro-cognitive stimulator.

11. The device of claim 1, wherein the neurodiagnostic module is operative to identify brain regions associated Alzheimer'"'"'s disease, dementia, autism spectrum disorder, mild cognitive impairment, memory loss, aging, ADHD, Parkinson'"'"'s disease, depression, addiction, substance abuse, schizophrenia, bipolar disorder, memory enhancement, intelligence enhancement, concentration enhancement, well-being or mood enhancement, self-esteem enhancement, language capabilities, verbal skills, vocabulary skills, articulation skills, alertness, focus, relaxation, perceptual skills, thinking, analytical skills, executive functions, sleep enhancement, motor skills, coordination skills, sports skills, musical skills, inter-personal skills, social skills and affective skills.

12. The device of claim 1, wherein said stimulator module system is operative to at least non-invasively apply stimulus energy to a left prefrontal region, frontal lobes, cingulate gyrus, hemispheres, temporal lobe, frontal lobe, parietal lobe, occipital lobe, amygdala region, cerebellum, hippocampus, anthreonal, Peabody, plaques, tangles, brain stem, medula, corpus collasum, subcortical region, cortex, gyrus, white matter and grey matter.

13. The device of claim 1, wherein the neurodiagnostic module is operative to identify brain regions associated Alzheimer'"'"'s disease and said stimulator module system is operative to at least non-invasively apply stimulus energy to an individual brain regions associated with Alzheimer'"'"'s disease.

14. The device of claim 13, wherein the analyzer system is operative to measure at least one property of an individual'"'"'s condition to obtain a measured property, the measured property being related to at least one of at least one brain region and at least one cognitive feature.

15. The device of claim 14, wherein the first stimulator comprises at least one non-invasive brain stimulator and at least one invasive brain stimulator, wherein the at least one non-invasive brain stimulator and the at least one invasive brain stimulator are configured to selectively stimulate the at least one brain region.

8. The device of claim 8, wherein the treatment module further includes a system of analyzers.

9. The device of claim 8, wherein said system of analyzers includes a brain stimulation analyzer, a cognitive stimulation analyzer, and a neuro-cognitive stimulation analyzer.

16. A system for assessing patient neuronal functions:

a neurodiagnostic module for identifying an individual'"'"'s brain regions of interest and measuring the functional activation or structural maps, or corresponding cognitive performance thereof;

a computational module identifying a patients deviant brain regions relative to corresponding statistically-established health norms, or from their corresponding statistical norms;

a brain trait module for determining whether the identified brain regions from said computational module statistically fits within known structural, functional, or cognitive pathophysiology of a particular brain-related disease, or within established norms for enhanced or excellent cognitive or behavioral performance for a particular task; and

a treatment system computing precise individual-based brain and cognitive stimulation parameters needed to stimulate generating at least non-invasively excitatory or inhibitory energy to stimulate the identified brain regions.

17. A method of assessing and treating cognitive, behavioral, or affective functions in a patient comprising:

neurodiagnostically identifying an individual'"'"'s brain regions of interest and associated with particular functional, structural, or cognitive abnormalities and measuring the functional activation or structural maps, or corresponding cognitive performance for a particular task (or tasks) or during a resting period;

identifying brain regions in an individual whose structure, function, or cognitive functions are deviant from their corresponding statistically-established health norms, or from their corresponding statistical norms for cognitively enhanced performance in a particular task;

determining whether the identified brain regions from said computational module statistically fits within known structural, functional, or cognitive pathophysiology of a particular brain-related disease, or within established norms for enhanced or excellent cognitive or behavioral performance for a particular task;

computing precise individual-based brain and cognitive stimulation parameters needed to stimulate the particular identified brain regions; and

at least non-invasively discharging energy to stimulate the identified brain regions associated with the particular functional, structural, or cognitive abnormalities. A system for assessing patient neuronal functions

18. A method of assessing and treating cognitive, behavioral, or affective functions in a patient comprising:

providing imaging devices to assist with identifying a patients deviant brain regions relative to corresponding statistically-established health norms, or from their corresponding statistical norms;

determining whether the identified brain regions statistically fits within known structural, functional, or cognitive pathophysiology of a particular brain-related disease, or within established norms for enhanced or excellent cognitive or behavioral performance for a particular task; and

a treatment system computing precise individual-based brain and cognitive stimulation parameters needed to stimulate generating at least non-invasively excitatory or inhibitory energy to stimulate the identified brain regions.

19. A method of treating cognitive impairments, comprising the steps of:

identifying at least one brain region associated with a cognitive impairment;

subjecting the at least one brain region to at least non-invasive excitatory or inhibitory stimulus energy; and

simultaneously, modifying a cognitive function associated with the at least one brain region.

20. The method of claim 19, further comprising the steps of:

subjecting the brain region to a treatment including at least one of cell replacement therapy, cell regenerative therapy and cell growth; and

optionally, subjecting the brain region to a pharmacological treatment.

21. A method of therapy for impaired cognitive functions, the method comprising the steps of:

providing a first stimulus to a pre-defined brain region of an individual without stimulating physically adjacent brain regions, the pre-defined brain region being functionally associated with an impaired cognitive function; and

providing at least one cognitive stimulus to the patient, to elicit a response involving the impaired cognitive function.

22. The method of claim 21, further comprising the steps of:

measuring at least one local brain function of the pre-defined brain region to obtain a local measurement;

comparing the local measurement to a normative value to obtain an evaluation data; and

adjusting, in response to the evaluation data, at least one of the steps of providing a first stimulus and providing at least one cognitive stimulus.

23. The method of claim 22, further comprising:

measuring the response to the first stimulus and to the cognitive stimulus, to obtain a cognition data; and

adjusting, based on the cognition data, at least one of the steps of providing a first stimulus and providing at least one cognitive stimulus.

24. A method of brain therapy, comprising:

providing an analyzer system including at least one of a brain analyzer and a cognitive analyzer;

the analyzer system measuring at least one property of an individual'"'"'s condition to obtain a measured property related to at least one of at least one brain region and at least one cognitive feature;

the analyzer system calculating a norm value from at least one brain region or at least one cognitive feature of healthy or diseased groups of individuals; and

the analyzer system comparing the measured property value with the norm value to provide a resultant value.

25. The method of claim 24, further including providing a neuro-cognitive stimulation analyzer.

26. A method of therapy, comprising:

measuring a local brain function of at least one brain region to produce a local measurement relative to a norm value of an individual;

evaluating the local measurement relative to a normative value of a group of individuals, to produce an evaluation datum;

adjusting at least one of one or more non-invasive stimulators and one or more one cognitive stimulators in response to the evaluation datum; and

providing stimuli from the at least one or more non-invasive stimulators and the least one or more cognitive stimulators to the at least one brain region.

27. The method of claim 26, further comprising:

measuring a response to the stimuli to produce a cognition measurement; and

adjusting at least one of the non-invasive and cognitive stimulators in response to the cognition measurement.

28. The method of claim 26, wherein the step of providing non-invasive stimuli includes providing electromagnetic stimuli and another form of neuronal stimuli, to selectively stimulate the at least one brain region.

29. A method of therapy for a cognitive symptom of a disease, comprising:

selectively stimulating at least one brain region functionally associated with a cognitive symptom, without physically stimulating adjacent regions; and

providing at least one cognitive stimulus selected to elicit a response involving the cognitive symptom.

30. The method of claim 29, further comprising:

measuring local brain function at the at least one brain region to produce a local measurement;

evaluating the local measurement relative to a normative value to produce an evaluation datum; and

adjusting at least one of the brain region stimulating and the at least one cognitive stimulus in response to the evaluation datum.

31. The method of claim 30, further comprising:

measuring the response to the stimulus to produce a cognition measurement; and

adjusting at least one of the selective stimulating and the at least one cognitive stimulus in response to the cognition measurement.

32. The method of claim 31, wherein the at least one brain region is a brain deficient region.

33. The method of claim 32, wherein the at least one brain region is associated with a memory function disease.

34. The method of claim 32, wherein the at least one brain region is associated with Alzheimer'"'"'s disease.

35. A method of neuronal therapy comprising:

providing an analyzer system including at least one of a brain analyzer and a cognitive analyzer;

the analyzer measuring at least one property of an individual'"'"'s condition, the measured property being related to at least one of at least one brain region and at least one cognitive feature;

the analyzer calculating a norm value from at least one brain region or at least one cognitive feature of healthy or diseased groups of individuals;

the analyzer comparing the measured property with the norm value and provide a resultant value;

providing a stimulator system including;

providing one or more non-invasive stimulators to selectively provide singular or multiple site stimuli to at least one brain region associated with the property;

providing one or more cognitive stimulators to selectively provide cognitive stimuli to at least one cognitive function relevant to the at least one property; and

providing a controller and interfacing the controller with the analyzer system and the stimulator system, the controller operating at least one of the one or more non-invasive brain stimulators and one or more one cognitive stimulators.